Dementia Dementia is a clinical syndrome characterized by a global deterioration of mental functioning in its cognitive, emotional and conative aspects

(Mayer-Gross, 1969). Dementia usually implies a long period of mental handicap and suffering for the patient, as well as severe strain and financial burden on the patients family, caregivers and society. Due to increasing life expectancy the number of people suffering from dementia will increase rapidly in both developed and developing countries (Cummings, 1992). Dementia, derived from the Latin demens (without mind), is an acquired clinical syndrome of long duration and usually progressive. The word dementia has acquired different meanings in different contexts. It may denote a clinical syndrome, regardless of etiology (Cummings, 1992), but also implies that the etiology is organic brain disease. Originally, the term was often used synonymously with insanity and madness in general, but when Kraepelin coined the concept of dementia praecox in 1893, it presumed an underlying organic defect (Karaeplin, 1893). The idea of dementia and its categorization has developed on the basis of accumulating evidence of clinicopathological entities and presumed etiological factors. Dementia is a clinical diagnosis that evokes strong emotions patients, relatives, doctors and laypeople fear and avoid it (Petersen, 2000). However, attitudes have changed in recent decades. General knowledge of dementia conditions has increased rapidly (Cummings, 1983). Genetic mutations and other specific etiologies of dementia are recognized, and the first generations of drugs for treatment and amelioration of AD (Alzheimers Disease) have been made available. Recently introduced terms

such as treatable dementia (Delaney,1982), reversible dementia and mild cognitive impairment highlight the clinical and etiological variability of such conditions (Alexopolos, 1993). AD is the most common disorder leading to dementia among both neurodegenerative and all types of dementias (Hejl, 2002). The disease (as well as the concept itself) is well known and yet unfamiliar due to its multifaceted presentation. AD is recognized as being not one disease, but a group of similar disorders, a syndrome that varies according to factors related to age, etiology, heredity, etc (Rabins, 1981). The clinical syndrome and neuropathological profile are viewed as well established but remain the subject of discussion regarding heterogeneity and subtypes, age characteristics and epidemiology, heredity and familial association, brain morphologic-pathologic substrates and characteristics, and possible vascular components (and thereby etiology as well) (SBU, 2008). The fact that dementia disorders include typical patterns similar to other chronic progressive incurable disorders has a number of implications for health economic analysis. The period of illness is long (several years or decades) (Zaudig, 1991). Due to the progressive and incurable nature of the various dementia diseases, stabilization or slowing down deterioration is a positive treatment effect even though improvement is rare (Flicker, 1991). Furthermore, the nature of the diseases does not suggest prolonged survival as the preferred outcome in terms of cost-effectiveness. Nonetheless, survival is of critical importance given that it impacts long-term costs from a societal perspective. Finally, most costs are not associated with traditional medical care (Knopman, 1995). Non-medical longterm care (such as nursing homes) and unpaid informal care account for most of the costs from a societal perspective (Max, 1996). Thus, when evaluating interventions in dementia care, the impact on the natural course of the disorders must be considered (Wimo, 1997). There may be transitions in terms of resource utilization, costs and

effectiveness between different stages in the course of dementia, and among different payers (for instance, from formal long-term care to informal home care, or vice versa) (Ernst, 1997). Thus, defining the parameters of a health economic analysis is crucial. Based on these considerations, a societal point of view is clearly of interest (Drummond, 1997). Such an analysis may include the perspectives of various payers, such as county councils and municipalities.

Issues about Dementia Identifying stigma is important because 36 million people have dementia worldwide and despite the best efforts in early diagnosis, treatments, care and support being offered by countries around the world we all struggle with the same basic issue: stigma prevents people from acknowledging symptoms and obtaining the help they need to continue to live a good quality of life. Stigma is an attribute, behavior, or reputation which is socially discrediting in a particular way: it causes an individual to be mentally classified by others in an undesirable, rejected stereotype rather than in an accepted, normal one (Goffman, 1963). The issue of financial support is a problem for many families, as reported in many of the narratives. This important issue deserves further investigation to uncover the sources of the problem and what can be done about it. There is a growing body of work that suggests that stigma promotes social exclusion and reluctance to seek help (Link & Phelan, 1999). The stigma associated with dementia leads to stereotyping of all people with dementia as somehow falling into one undifferentiated category. In the early stage of dementia, this stereotyping inevitably leads to devaluing the potential contribution of the person with dementia in conversation, which results in less interaction and an eroding of the relationship of the person with dementia and family members and friends (Corrigan, 2004). In all stages, the stigma associated with dementia

also leads to a focus on the ways in which the person is impaired, rather than on his or her remaining strengths and ability to enjoy many activities and interactions with other people. This deprives the person with dementia of the companionship of family and friends; the resulting isolation and lack of stimulation causes disability beyond that caused by the illness itself. Stigma and old age The stigma of dementia is made more severe because dementia is generally a disease of old age. Older age is also stigmatised, and considered to be a time of increased vulnerability and dependence (Nelson, 2004). Since the general expectation is that people will suffer cognitive decline with age, neither they nor their relatives are motivated to seek medical evaluation to determine the cause of the decline. Physicians are reluctant to discuss cognitive symptoms with their patients because of the stigma associated with it and the sense that nothing can be done. Stigma has been ide ntiied as a major barrier to seeking a diagnostic evaluation (Koch, 2010). Moreover, stigmatic beliefs of primary care physicians and therapeutic nihilism lead them to avoid evaluating cognitive function until the illness is so apparent that it cannot be ignored (Werner & Giveon, 2008). One randomised controlled trial conducted in the Asian community found that brief exposure to information about the symptoms of dementia, in the form of vignettes about people with the illness, led to a significant reduction in stigma (Cheng, 2011). In this study, conducted in Hong Kong, older adults and those who were less educated had more stigmatic beliefs than younger, better educated adults. Those who thought dementia was treatable had fewer stigmatic beliefs. The authors pointed out, as did Werner (2010), that dementia is considered to be a family disgrace, stigma by association. An important consequence of the stigma associated with old age in general, and dementia in particular, is an assumption of incapacity to make decisions. We believe that this assumption

can lead to a premature loss of autonomy, and dignity, which in turn fuels the loss of self-esteem associated with stigma and dementia (Batsch & Mittelman, 2012). The negative perceptions of individuals and society regarding dementia may lead to the isolation of people with dementia and their careers, and also reinforce and extend isolation caused by the effects of the disease. There is a widespread assumption that people with dementia cannot take part in ordinary activities. There is also a widely held perception that they have no capacity for pleasure and cannot enjoy life. While the symptoms associated with dementia affect the way a person with dementia interacts with others, there are many activities, sometimes with adjustments, in which they can participate. Both people with dementia and their family members will beneit from continuing to engage in as many activities as they can. Moreover, people with dementia should be involved in decisions that affect them for as long as possible, to maintain their dignity and self-esteem (Batsch & Mittelman, 2012). Through the studies included in this review, the researchers had concluded that one of the reasons people and the care-takers of the people who are suffering from Dementia are having a difficult time seeking help to treat their condition is because of the lack of knowledge about it, thus leading to stigma, thinking Dementia is something that should be just accepted. The materials in this review had helped the researchers find ways on how to address dementia properly. The first step to deal with Dementia is to become aware of what Dementia really is, this will allow people to fight the fear of having it and treat it properly.

BIBLIOGRAPHY References: Alexopoulos GS, et al. (1993). The course of geriatric depression with "reversible dementia": a controlled study. Am J Psychiatry Batsch, N & Mittelman M. (2012). Overcoming the stigma of dementia. Alzheimers Disease International: London. Cheng, ST, et al. (2011). The effects of exposure to scenarios about dementia on stigma and attitudes toward dementia care in a Chinese community. Int Psychogeriatr. Corrigan, P. (2004). How stigma interferes with mental health care. American Psychologist. Cummings JL, Benson DF. (1992.) Dementia: a clinical approach. 2nd ed. Boston: Butterworth-Heinemann Delaney, P. (1982). Dementia: the search for treatable causes. South Med J Drummond, M., O'Brien B., Stoddart, G. & Torrance, G. (1997.). Methods for the economic evaluation of health care programmes. Oxford, UK: Oxford University Press; Ernst, RL & Hay, JW. (1997). Economic research on Alzheimer disease: a review of the literature. Alzheimer Dis Assoc Disord Flicker C, et al. (1991). Mild cognitive impairment in the elderly: predictors of dementia. Neurology. Glennie, J. (1997). The efficacy of tacrine and the measurement of outcomes in Alzheimer's disease. Ottawa: The Canadian Coordinating Office for Health Technology Assessment (CCOHTA); Goffman, E. (1963). Stigma: Notes on the Management of Spoiled Identity. Englewood Cliffs, New Jersey: Prentice-Hall Hejl, A, et al. (2002). Potentially reversible conditions in 1 000 consecutive memory clinic patients. J Neurol Neurosurg Psychiatry. Knopman, D. (1995). Tacrine for Alzheimer's disease. Costs and benefits. Pharmacoeconomics.

Koch, T, Iliffe, S & EVIDEM-ED project. (2010). Rapid appraisal of barriers to the diagnosis and management of patients with dementia in primary care: a systematic review. BMC Family Practice. Lindgren, B. (1981). Costs of illness in Sweden 1964-1975. Lund: Liber. Link, BG & Phelan, JC. (1999). Labeling and stigma. CS Aneshensel & Phelan JC. Handbook of Sociology of Mental Health. Dordrecht, Netherlands : Kluwer Max, W. (1996). The cost of Alzheimer's disease. Will drug treatment ease the burden? Pharmacoeconomics. Mayer-Gross W, et al. (1969). Clinical Psychiatry. 2 ed. London: Tindall & Carsell. Molnar FJ & Dalziel WB. (1997). The pharmacoeconomics of dementia therapies. Bringing the clinical, research and economic perspectives together. Drugs Aging. Nelson, T. (2004). Ageism: Stereotyping and Prejudice Against Older Persons. Cambridge, MA : MIT Press Petersen RC. (2000). Mild cognitive impairment or questionable dementia? ArchNeurol Rabins PV. (1981). The prevalence of reversible dementia in a psychiatric hospital. HospCommunity Psychiatry Werner, P & Giveon, SM. (2008). Discriminatory behavior of family physicians toward a person with Alzheimers disease. International Psychogeriatrics. Werner, P, Goldstein, D & Buchbinder, E. (2010). Subjective experience of family stigma as reported by children of Alzheimers disease patients. Qualitative Health Research. Wimo A, Ljunggren G, Winblad B. (1997). Costs of dementia and dementia care: a review. Int J Geriatr Psychiatry Zaudig M. (1992). A new systematic method of measurement and diagnosis of "mild cognitive impairment" and dementia according to ICD-10 and DSM-III-R criteria. Int Psychogeriatry